Paraskevi C. Fragkou

Dr. Paraskevi C. Fragkou

4th Department of Internal Medicine, University General Hospital Attikon, Athens, Greece
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
IGIoanna-Evdokia Galani
Ioanna-Evdokia Galani
NRNikoletta Rovina
Nikoletta Rovina
VLVicky Lampropoulou
Vicky Lampropoulou
VTVasiliki Triantafyllia
Vasiliki Triantafyllia
MMMaria Manioudaki
Maria Manioudaki
V0VAT Number: EL 090050626
VAT Number: EL 090050626

10 June 2022 in Reviews in Medical Virology
Verified
Journal Article
Open access
HKHanna Krumbein
Hanna Krumbein
LKLara S. Kümmel
Lara S. Kümmel
Paraskevi C. FragkouParaskevi C. Fragkou
Paraskevi C. Fragkou
CTClemens Thölken
Clemens Thölken
BHBen L. Hünerbein
Ben L. Hünerbein
CSChrysanthi Skevaki
Chrysanthi Skevaki
The aim of this systematic review and meta‐analysis was to critically assess the published literature related to community‐acquired viral co‐infections and COVID‐19 and to evaluate the prevalence, most identified co‐pathogens, and relevant risk factors. Furthermore, we aimed to examine the clinical features and outcomes of co‐infected compared to mono‐infected COVID‐19 patients. We systematically searched PubMed, Web of Science, Embase, Scopus, and The Cochrane Library for studies published from 1 November 2019 to 13 August 2021. We included patients of all ages and any COVID‐19 severity who were screened for respiratory viral co‐infection within 48 h of COVID‐19 diagnosis. The main outcome was the proportion of patients with a respiratory viral co‐infection. The systematic review was registered to PROSPERO (CRD42021272235). Out of 6053 initially retrieved studies, 59 studies with a total of 16,643 SARS‐CoV‐2 positive patients were included. The global pooled prevalence was 5.01% (95% CI 3.34%–7.27%; I2 = 95%) based on a random‐effects model, with Influenza Viruses (1.54%) and Enteroviruses (1.32%) being the most prevalent pathogens. Subgroup analyses showed that co‐infection was significantly higher in paediatric (9.39%) than adult (3.51%) patients (p‐value = 0.02). Furthermore, co‐infected patients were more likely to be dyspnoeic and the odds of fatality (OR = 1.66) were increased. Although a relatively low proportion of COVID‐19 patients have a respiratory viral co‐infection, our findings show that multiplex viral panel testing may be advisable in patients with compatible symptoms. Indeed, respiratory virus co‐infections may be associated with adverse clinical outcomes and therefore have therapeutic and prognostic implications.

8 October 2020 in BJPsych Open
Verified
Journal Article
Open access
PDF file
NCNicholas W. S. Chew
Nicholas W. S. Chew
JNJinghao Nicholas Ngiam
Jinghao Nicholas Ngiam
Benjamin Yong-Qiang TanBenjamin Yong-Qiang Tan
Benjamin Yong-Qiang Tan
STSai-Meng Tham
Sai-Meng Tham
CTCeline Yan-Shan Tan
Celine Yan-Shan Tan
VSVijay K. Sharma
Vijay K. Sharma
Background: The coronavirus disease 2019 (COVID-19) pandemic has led to significant strain on front-line healthcare workers. Aims: In this multicentre study, we compared the psychological outcomes during the COVID-19 pandemic in various countries in the Asia-Pacific region and identified factors associated with adverse psychological outcomes. Method: From 29 April to 4 June 2020, the study recruited healthcare workers from major healthcare institutions in five countries in the Asia-Pacific region. A self-administrated survey that collected information on prior medical conditions, presence of symptoms, and scores on the Depression Anxiety Stress Scales and the Impact of Events Scale-Revised were used. The prevalence of depression, anxiety, stress and post-traumatic stress disorder (PTSD) relating to COVID-19 was compared, and multivariable logistic regression identified independent factors associated with adverse psychological outcomes within each country. Results: A total of 1146 participants from India, Indonesia, Singapore, Malaysia and Vietnam were studied. Despite having the lowest volume of cases, Vietnam displayed the highest prevalence of PTSD. In contrast, Singapore reported the highest case volume, but had a lower prevalence of depression and anxiety. In the multivariable analysis, we found that non-medically trained personnel, the presence of physical symptoms and presence of prior medical conditions were independent predictors across the participating countries. Conclusions: This study highlights that the varied prevalence of psychological adversity among healthcare workers is independent of the burden of COVID-19 cases within each country. Early psychological interventions may be beneficial for the vulnerable groups of healthcare workers with presence of physical symptoms, prior medical conditions and those who are not medically trained.

1 September 2020 in EBioMedicine
Verified
Journal Article
Open access
SSShima Shahjouei
Shima Shahjouei
SNSoheil Naderi
Soheil Naderi
JLJiang Li
Jiang Li
AKAyesha Khan
Ayesha Khan
DCDurgesh Chaudhary
Durgesh Chaudhary
Ramin ZandRamin Zand
Ramin Zand
There is an increased attention to stroke following SARS-CoV-2. The goal of this study was to better depict the short-term risk of stroke and its associated factors among SARS-CoV-2 hospitalized patients. This multicentre, multinational observational study includes hospitalized SARS-CoV-2 patients from North and South America (United States, Canada, and Brazil), Europe (Greece, Italy, Finland, and Turkey), Asia (Lebanon, Iran, and India), and Oceania (New Zealand). The outcome was the risk of subsequent stroke. Centres were included by non-probability sampling. The counts and clinical characteristics including laboratory findings and imaging of the patients with and without a subsequent stroke were recorded according to a predefined protocol. Quality, risk of bias, and heterogeneity assessments were conducted according to ROBINS-E and Cochrane Q-test. The risk of subsequent stroke was estimated through meta-analyses with random effect models. Bivariate logistic regression was used to determine the parameters with predictive outcome value. The study was reported according to the STROBE, MOOSE, and EQUATOR guidelines. We received data from 26,175 hospitalized SARS-CoV-2 patients from 99 tertiary centres in 65 regions of 11 countries until May 1st, 2020. A total of 17,799 patients were included in meta-analyses. Among them, 156(0.9%) patients had a stroke—123(79%) ischaemic stroke, 27(17%) intracerebral/subarachnoid hemorrhage, and 6(4%) cerebral sinus thrombosis. Subsequent stroke risks calculated with meta-analyses, under low to moderate heterogeneity, were 0.5% among all centres in all countries, and 0.7% among countries with higher health expenditures. The need for mechanical ventilation (OR: 1.9, 95% CI:1.1–3.5, p = 0.03) and the presence of ischaemic heart disease (OR: 2.5, 95% CI:1.4–4.7, p = 0.006) were predictive of stroke. The results of this multi-national study on hospitalized patients with SARS-CoV-2 infection indicated an overall stroke risk of 0.5%(pooled risk: 0.9%). The need for mechanical ventilation and the history of ischaemic heart disease are the independent predictors of stroke among SARS-CoV-2 patients. None.

1 August 2020 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
Paraskevi C. FragkouParaskevi C. Fragkou
Paraskevi C. Fragkou
DBD. Belhadi
D. Belhadi
NPN. Peiffer-Smadja
N. Peiffer-Smadja
Charalampos D. MoschopoulosCharalampos D. Moschopoulos
Charalampos D. Moschopoulos
FLF.-X. Lescure
F.-X. Lescure
STS. Tsiodras
S. Tsiodras

1 August 2016 in Annals of Surgery
Verified
Journal Article
Closed access
ELE. Rebecca Longbottom
E. Rebecca Longbottom
HTHew David Torrance
Hew David Torrance
HOHelen C. Owen
Helen C. Owen
Paraskevi C. FragkouParaskevi C. Fragkou
Paraskevi C. Fragkou
CHCharles J. Hinds
Charles J. Hinds
MOMichael J. O’dWyer
Michael J. O’dWyer
The aim of this study was to evaluate the role of interleukin (IL)-6 pathways in postoperative immune suppression and to assess the reversibility of this phenomenon. The postoperative period is characterized by increased IL-6 production and features of immune suppression. In vitro, IL-6 mediates anti-inflammatory effects through inhibition of interferon gamma (IFN-γ) pathways. The significance of the immunomodulatory effects of IL-6 in the clinical setting of postoperative immune suppression remains unclear. Patients over 45 years old undergoing elective surgery, involving the gastrointestinal tract, were recruited. IL-6 levels were assayed using an enzyme linked immunosorbent assay preoperatively, and at 24 and 48 hours. Peripheral blood mononuclear cells from healthy volunteers were cultured in perioperative serum and CD14Human Leukocyte Antigen-DR (HLA-DR) [monocyte HLA-DR (mHLA-DR)] geometric mean florescent intensity was measured in the presence and absence of IL-6 neutralizing antibody and recombinant IFN-γ. Of the 108 patients, 41 developed a postoperative infection. The IL-6 levels increased 19-fold from the preoperative sample to 24 hours postoperatively (P < 0.0001). Higher IL-6 levels at 24 (P = 0.0002) and 48 hours (P = 0.003) were associated with subsequent postoperative infectious complications. mHLA-DR mean florescent intensity fell when healthy peripheral blood mononuclear cells were cultured with postoperative serum compared with preoperative serum (P = 0.008). This decrease was prevented by the presence of IFN-γ in the culture media, but not by the presence of IL-6-neutralizing antibody. IL-6 levels increase after a major surgery and are associated with an increased susceptibility to postoperative infections. Serum obtained from postoperative patients induces an immunosuppressive response, reflected in reduced mHLA-DR levels, mediated through IL-6 independent pathways and is reversible with IFN-γ. These data may have therapeutic implications for the prevention of infection in patients undergoing major surgery.